1.
Synthesis and characterization of compounds 2a, 2b, 2d, 4, and 5-9
Synthesis of 2a. 20 mg scale, DMF, rt, purified 3% MeOH/CH2Cl2 to yield an off-white solid (14 mg, 64% 4-Propargyloxybenzyl alcohol (4) was synthesized as previously published [1] Synthesis of 4-Propargyloxybenzyl chloride (5). Method derived from De Luca et al. [2] Cyanuric chloride (663 mg, 3.67 mmol) was stirred as a suspension in DMF (700 µL) for 1 hr, after which p-propargyloxybenzyl alcohol (542 mg, 3.34 mmol) in CH2CL2 (5 mL) was added and the reaction stirred at ambient temperature overnight. The reaction was diluted with CH2CL2 (25 mL) and washed with sat.
bicarb. The organic phase was extracted with CH2CL2 (2 ×15 mL), dried over MgSO4 and concentrated in vacuo. The crude product was further purified with column chromatography (20-60% EtOAc/n-hexane) to yield the title compound as a colourless oil (501 mg, 2.77 mmol, 83%). 1 
S5
Synthesis of 2,6-bis(propargyloxy)benzyl alcohol (8). Intermediate 7 (5.37 g, 20 mmol) was dissolved in THF and cooled to 0 ºC for the addition of LiAlH4 (1 M in THF, 24 mL) before warming to ambient temperature and stirring overnight. The reaction was quenched at 0 ºC with 10% NaOH (40 mL), stirring for 30 min. The aqueous phase was extracted with CH2Cl2 (3 × 70 mL) and the combined organic phases washed with brine (40 mL), dried over anhydrous MgSO4 and concentrated in vacuo.
The crude alcohol was purified by flash column chromatography (30% EtOAc/n-hexane) to yield the title compound as a white solid (2.74 g, 12.6 mmol, 63%). 1 
NMR spectra of 2a-d
1 H NMR spectra of 2a in DMSO-d6 at 300 K 13 C NMR spectra of 2a in DMSO-d6 at 300 K S7 1 H NMR spectra of 2b in DMSO-d6 at 300 K 13 C NMR spectra of 2b in DMSO-d6 at 300 K S8 1 H NMR spectra of 2c in DMSO-d6 at 300 K 13 C NMR spectra of 2c in DMSO-d6 at 300 K S9 1 H NMR spectra of 2d in DMSO-d6 at 300 K 13 C NMR spectra of 2d in DMSO-d6 at 300 K S10
Synthesis and characterization of Pd-microdevices
NovaSyn TG amino resins HL (1.6 g, 0.24 NH2 mmol/g, particle size 30 μm) and palladium acetate (263 mg, 1.17 mmol) were added into a 25 mL Biotage microwave vial (Biotage). Next, toluene (10 mL) was added to the vial and heated to 80 °C for 10 min, then stirred at room temperature for an additional 2 h. To ensure appropriate controls, each combination activation assay plate had the following wells in triplicate: DMSO (0.1% v/v); Pd-devices (1 mg/mL); Pro-5FU alone (100 µM); 2c alone (10 or 100 nM for HCT116 and U-87 respectively); 5FU alone (30 and 100 µM); 1 alone (10 or 100 nM for HCT116
and U-87 respectively); Pro-5FU+2c combination (100 µM Pro-5FU + 10 or 100 nM 2c for HCT116 and U-87 respectively); 5FU+1 (30 and 100 µM 5FU + 10 or 100 nM 1 for HCT116 and U-87 respectively);
and Pro-5FU+2c+Pd-devices combination activation assay (30 and 100 µM Pro-5FU + 10 or 100 nM 2c for HCT116 and U-87 respectively). Plates were repeated in triplicate for each experiment.
Prodrug-into-drug conversion studies -delayed dual therapy activation Cells were plated as described above and incubated for 48 h prior to treatment. Each well was then replaced with fresh media (90 µL) or fresh media containing Pd-devices (90 µL + 0.1 mg devices) for prodrug activation wells. Cells were then treated with both drugs (1 + 5FU) or both prodrugs (2c + Pro-5FU) on day 1, or two days apart (i.e. one treatment of either 1/2c or 5FU/Pro-5FU on day 1 and the second treatment on day 3). Concentrations of treatments remained constant at: [1] and [2c] = 300 nM,
[5FU] and [Pro-5FU] = 100 µM. Control wells with plus 0.2% v/v DMSO were also treated simultaneously or two days apart. Cell viability was measured on day 5 as before. (control, grey); 1 mg/mL of Pd-devices (-ve control, black stripes); 1 + 5FU (both added on day 1, yellow); 1 (added on day 1) + 5FU (added on day 3, orange); 5FU (added on day 1, blue) + 1 (added on day 3). Experiments: 1 mg/mL of Pd-devices + 2c + Pro-5FU (both added on day 1, yellow with black stripes); 1 mg/mL of Pd-devices +2c (added on day 1) + Pro-5FU (added on day 3, green with black stripes); 1 mg/mL of Pd-devices + Pro-5FU (added on day 1, blue with black stripes) + 2c (added on day 3). Error bars: ± SEM.
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